glp-1 and macular degeneration Agonists May Lower Risk of The Link between GLP-1 Drugs

However, a post hoc analysis of semaglutide trials found no increased risk of kidney-related adverse events compared with active comparators [113]

Other GLP-1 Drugs in Canada Several older GLP-1 medications are still authorised for sale in Canada, but these are prescribed less frequently as newer alternatives have taken over

It some cases it could cause people to pursue treatment without guidance and overlook the complex, interconnected nature of our bodies

, Fekete, C

Future studies are needed to identify which people with MS are most likely to benefit from taking a GLP-1, the safest dosing strategies, and whether these medications have long-term disease-modifying effects in MS, she says